JUBILANT PHARMOVA
|
JUBILANT PHARMOVA Last 5 Year Income Statement History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
INCOME : | |||||
Gross Sales | ₹7,235 Cr | ₹6,703 Cr | ₹6,282 Cr | ₹6,130 Cr | ₹6,099 Cr |
Sales | ₹5,303 Cr | ₹5,044 Cr | ₹4,519 Cr | ₹4,292 Cr | ₹4,301 Cr |
Job Work/ Contract Receipts | - | - | - | - | - |
Processing Charges / Service Income | ₹1,889 Cr | ₹1,601 Cr | ₹1,700 Cr | ₹1,767 Cr | ₹1,663 Cr |
Revenue from property development | - | - | - | - | - |
Other Operational Income | ₹42 Cr | ₹58 Cr | ₹62 Cr | ₹71 Cr | ₹135 Cr |
Less: Excise Duty | - | - | - | - | - |
Net Sales | ₹7,235 Cr | ₹6,703 Cr | ₹6,282 Cr | ₹6,130 Cr | ₹6,099 Cr |
EXPENDITURE : | |||||
Increase/Decrease in Stock | ₹35 Cr | ₹78 Cr | ₹-41 Cr | ₹-62 Cr | ₹20 Cr |
Raw Material Consumed | ₹2,282 Cr | ₹2,063 Cr | ₹1,919 Cr | ₹1,550 Cr | ₹1,516 Cr |
Opening Raw Materials | ₹425 Cr | ₹433 Cr | ₹364 Cr | ₹347 Cr | ₹578 Cr |
Purchases Raw Materials | ₹1,893 Cr | ₹1,813 Cr | ₹1,735 Cr | ₹1,365 Cr | ₹1,118 Cr |
Closing Raw Materials | ₹332 Cr | ₹425 Cr | ₹433 Cr | ₹364 Cr | ₹347 Cr |
Other Direct Purchases / Brought in cost | ₹297 Cr | ₹241 Cr | ₹252 Cr | ₹202 Cr | ₹168 Cr |
Other raw material cost | - | - | - | - | - |
Power & Fuel Cost | ₹154 Cr | ₹149 Cr | ₹167 Cr | ₹134 Cr | ₹106 Cr |
Electricity & Power | ₹154 Cr | ₹149 Cr | ₹167 Cr | ₹134 Cr | ₹106 Cr |
Oil, Fuel & Natural gas | - | - | - | - | - |
Coals etc | - | - | - | - | - |
Other power & fuel | - | - | - | - | - |
Employee Cost | ₹2,268 Cr | ₹2,216 Cr | ₹2,166 Cr | ₹2,043 Cr | ₹1,923 Cr |
Salaries, Wages & Bonus | ₹1,887 Cr | ₹1,867 Cr | ₹1,807 Cr | ₹1,705 Cr | ₹1,616 Cr |
Contributions to EPF & Pension Funds | ₹190 Cr | ₹181 Cr | ₹179 Cr | ₹164 Cr | ₹154 Cr |
Workmen and Staff Welfare Expenses | ₹187 Cr | ₹159 Cr | ₹177 Cr | ₹173 Cr | ₹153 Cr |
Other Employees Cost | ₹4.30 Cr | ₹8.50 Cr | ₹3.70 Cr | ₹1.12 Cr | ₹0.25 Cr |
Other Manufacturing Expenses | ₹546 Cr | ₹523 Cr | ₹581 Cr | ₹562 Cr | ₹449 Cr |
Sub-contracted / Out sourced services | - | - | - | - | - |
Processing Charges | ₹15 Cr | ₹14 Cr | ₹20 Cr | ₹95 Cr | ₹71 Cr |
Repairs and Maintenance | ₹219 Cr | ₹211 Cr | ₹204 Cr | ₹159 Cr | ₹153 Cr |
Packing Material Consumed | - | - | - | - | - |
Other Mfg Exp | ₹313 Cr | ₹299 Cr | ₹357 Cr | ₹309 Cr | ₹226 Cr |
General and Administration Expenses | ₹495 Cr | ₹475 Cr | ₹464 Cr | ₹432 Cr | ₹388 Cr |
Rent , Rates & Taxes | ₹117 Cr | ₹110 Cr | ₹95 Cr | ₹80 Cr | ₹72 Cr |
Insurance | ₹50 Cr | ₹45 Cr | ₹43 Cr | ₹44 Cr | ₹46 Cr |
Printing and stationery | ₹12 Cr | ₹11 Cr | ₹11 Cr | ₹11 Cr | ₹10 Cr |
Professional and legal fees | ₹139 Cr | ₹159 Cr | ₹158 Cr | ₹182 Cr | ₹163 Cr |
Traveling and conveyance | ₹70 Cr | ₹64 Cr | ₹60 Cr | ₹37 Cr | ₹16 Cr |
Other Administration | ₹107 Cr | ₹86 Cr | ₹96 Cr | ₹78 Cr | ₹81 Cr |
Selling and Distribution Expenses | ₹206 Cr | ₹214 Cr | ₹162 Cr | ₹210 Cr | ₹177 Cr |
Advertisement & Sales Promotion | ₹69 Cr | ₹66 Cr | ₹41 Cr | ₹26 Cr | ₹16 Cr |
Sales Commissions & Incentives | ₹35 Cr | ₹36 Cr | ₹39 Cr | ₹35 Cr | ₹35 Cr |
Freight and Forwarding | ₹59 Cr | ₹61 Cr | ₹72 Cr | ₹95 Cr | ₹98 Cr |
Handling and Clearing Charges | - | - | - | - | - |
Other Selling Expenses | ₹43 Cr | ₹51 Cr | ₹8.90 Cr | ₹54 Cr | ₹28 Cr |
Miscellaneous Expenses | ₹75 Cr | ₹84 Cr | ₹88 Cr | ₹104 Cr | ₹123 Cr |
Bad debts /advances written off | - | - | - | - | - |
Provision for doubtful debts | - | - | - | - | - |
Losson disposal of fixed assets(net) | - | - | ₹2.70 Cr | ₹3.37 Cr | ₹6.69 Cr |
Losson foreign exchange fluctuations | - | ₹4.20 Cr | - | ₹46 Cr | ₹64 Cr |
Losson sale of non-trade current investments | ₹1.70 Cr | - | ₹5.00 Cr | - | - |
Other Miscellaneous Expenses | ₹73 Cr | ₹80 Cr | ₹80 Cr | ₹54 Cr | ₹52 Cr |
Less: Expenses Capitalised | - | - | - | - | - |
Total Expenditure | ₹6,061 Cr | ₹5,802 Cr | ₹5,506 Cr | ₹4,974 Cr | ₹4,702 Cr |
Operating Profit (Excl OI) | ₹1,174 Cr | ₹901 Cr | ₹776 Cr | ₹1,156 Cr | ₹1,396 Cr |
Other Income | ₹57 Cr | ₹69 Cr | ₹38 Cr | ₹11 Cr | ₹18 Cr |
Interest Received | ₹37 Cr | ₹26 Cr | ₹9.80 Cr | ₹2.45 Cr | ₹8.10 Cr |
Dividend Received | - | - | - | - | - |
Profit on sale of Fixed Assets | - | - | - | - | - |
Profits on sale of Investments | - | - | - | - | - |
Provision Written Back | - | - | - | - | - |
Foreign Exchange Gains | ₹0.60 Cr | - | ₹17 Cr | - | - |
Others | ₹20 Cr | ₹43 Cr | ₹11 Cr | ₹8.84 Cr | ₹9.54 Cr |
Operating Profit | ₹1,231 Cr | ₹970 Cr | ₹815 Cr | ₹1,168 Cr | ₹1,414 Cr |
Interest | ₹240 Cr | ₹272 Cr | ₹188 Cr | ₹145 Cr | ₹184 Cr |
InterestonDebenture / Bonds | - | - | - | - | - |
Interest on Term Loan | - | - | - | - | - |
Intereston Fixed deposits | - | - | - | - | - |
Bank Charges etc | ₹19 Cr | ₹16 Cr | ₹20 Cr | ₹7.25 Cr | ₹11 Cr |
Other Interest | ₹221 Cr | ₹256 Cr | ₹169 Cr | ₹138 Cr | ₹173 Cr |
PBDT | ₹990 Cr | ₹697 Cr | ₹626 Cr | ₹1,022 Cr | ₹1,230 Cr |
Depreciation | ₹369 Cr | ₹382 Cr | ₹554 Cr | ₹382 Cr | ₹349 Cr |
Profit Before Taxation & Exceptional Items | ₹622 Cr | ₹315 Cr | ₹72 Cr | ₹640 Cr | ₹881 Cr |
Exceptional Income / Expenses | ₹360 Cr | ₹-169 Cr | ₹-57 Cr | - | ₹-21 Cr |
Profit Before Tax | ₹981 Cr | ₹171 Cr | ₹28 Cr | ₹630 Cr | ₹871 Cr |
Provision for Tax | ₹144 Cr | ₹98 Cr | ₹93 Cr | ₹217 Cr | ₹297 Cr |
Current Income Tax | ₹219 Cr | ₹200 Cr | ₹189 Cr | ₹181 Cr | ₹264 Cr |
Deferred Tax | ₹-56 Cr | ₹-103 Cr | ₹-100 Cr | ₹31 Cr | ₹32 Cr |
Other taxes | ₹-19 Cr | ₹0.40 Cr | ₹3.60 Cr | ₹6.34 Cr | ₹1.61 Cr |
Profit After Tax | ₹836 Cr | ₹73 Cr | ₹-65 Cr | ₹413 Cr | ₹574 Cr |
Extra items | - | - | - | - | ₹262 Cr |
Minority Interest | ₹3.10 Cr | ₹4.40 Cr | ₹3.90 Cr | ₹0.92 Cr | ₹0.26 Cr |
Share of Associate | - | - | - | - | - |
Other Consolidated Items | - | - | - | - | - |
Consolidated Net Profit | ₹839 Cr | ₹77 Cr | ₹-61 Cr | ₹414 Cr | ₹836 Cr |
Adjustments to PAT | - | - | - | - | - |
Profit Balance B/F | ₹4,540 Cr | ₹4,537 Cr | ₹4,685 Cr | ₹4,318 Cr | ₹3,845 Cr |
Appropriations | ₹5,379 Cr | ₹4,614 Cr | ₹4,624 Cr | ₹4,732 Cr | ₹4,681 Cr |
General Reserves | - | - | - | - | - |
Proposed Equity Dividend | - | - | - | - | - |
Corporate dividend tax | - | - | - | - | - |
Other Appropriation | ₹77 Cr | ₹74 Cr | ₹87 Cr | ₹47 Cr | ₹363 Cr |
Equity Dividend % | ₹500.00 | ₹500.00 | ₹500.00 | ₹500.00 | ₹500.00 |
Earnings Per Share | ₹53.13 | ₹4.88 | ₹-3.84 | ₹26.01 | ₹52.51 |
Adjusted EPS | ₹53.13 | ₹4.88 | ₹-3.84 | ₹26.01 | ₹52.51 |
Compare Income Statement of peers of JUBILANT PHARMOVA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
JUBILANT PHARMOVA | ₹18,141.1 Cr | 7% | 3.4% | 16.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹382,370.0 Cr | 0.7% | 0.4% | -12.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹160,087.0 Cr | -1.7% | 2% | 16.7% | Stock Analytics | |
CIPLA | ₹126,308.0 Cr | -0.9% | 5.3% | -3.7% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹121,614.0 Cr | -0.1% | 0.6% | 6.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹108,845.0 Cr | 4.1% | 7.6% | -3% | Stock Analytics |
JUBILANT PHARMOVA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
JUBILANT PHARMOVA | 7% |
3.4% |
16.6% |
SENSEX | 1.1% |
1% |
-0.9% |
You may also like the below Video Courses